5mg Benazecare Flavour Tablet - per Tablet

5mg Benazecare Flavour Tablet - per Tablet View larger

£ 1.09 inc. VAT

5mg Benazecare is used for the treatment of congestive heart failure in dogs and the treatment of chronic renal insufficiency in cats. VET PRESCRIPTION REQUIRED

More details


Data sheet

Target Animal:Dogs and Cats
Related Condition:Treatment of congestive heart failure in dogs
Pet Prescription Required?:Yes (For UK Orders)
Active Ingredient:Benazepril
Product Name:5mg Benazecare Flavour Tablet - per Tablet
Pack Size:Sold Individually

More info

5mg Benazecare Tablets

This medication may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase this item if you have or are in the process of arranging such a prescription. See information bar for further details.

Benazecare are pale yellow film-coated divisible oval tablets. Each Benazecare tablet contains 5 mg benazepril hydrochloride.

Benazecare is indicated for the treatment of congestive heart failure in dogs and the treatment of chronic renal insufficiency in cats.

After oral administration benazepril is rapidly absorbed from the gastrointestinal tract and hydrolysed into benazeprilat a highly specific and potent inhibitor of angiotensin converting enzyme (ACE). Benazeprilat produces significant inhibition of plasma ACE activity for more than 24 hours after a single dose in both dogs and cats. Inhibition of ACE leads to a reduced conversion of inactive angiotensin I into angiotensin II and therefore reduction in the effects mediated by angiotensin II including vasoconstriction of both arteries and veins retention of sodium and water by the kidney and remodelling effects (including pathological cardiac hypertrophy and degenerative renal changes).

In dogs with heart failure benazeprilat lowers the blood pressure and volume loading effect on the heart.

In cats with renal insufficiency Benazecare reduces the protein loss in urine and normalises the elevated glomerular capillary pressure and reduces systemic blood pressure. Reduction in glomerular hypertension retards the progression of kidney disease by inhibition of further damage to the kidneys. Benazecare has been shown to increase the appetite quality of life and the survival time of cats particularly in advanced disease.

Benazeprilat is excreted equally by both biliary and urinary routes in dogs and primarily via the biliary route in cats and therefore no adjustment of the dose of Benazecare is necessary in the treatment of cases with renal insufficiency. Onset of clinical efficacy can be expected approximately 1 week after initiation of treatment with benazepril hydrochloride.   Benazecare

Dosage and administration
In both dogs and cats Benazecare should be given orally once daily with or without food. The duration of treatment is unlimited. Congestive Heart Failure in Dogs The recommended dose is 0.25 mg benazepril hydrochloride/kg body weight to be given orally once daily. The dose may be doubled still administered once daily if judged clinically necessary and advised by the veterinary surgeon. The dosing regime is as follows: BENAZECARE 5 Weight of dog (kg) Standard dose Double dose 5-10 0.5 tablet/day 1 tablet/day 11-20 1 tablet/day 2 tablets/day Benazepril may be given with digoxin diuretics and anti-arrhythmic drugs as necessary. Chronic renal insufficiency in cats The recommended oral dose is 0.5 mg benazepril hydrochloride/kg body weight according to the following table: Weight of cat (kg) BENAZECARE 5 2.5 - 5 0.5 tablet/day >5 - 10 1 tablet/day

Legal category
Benazecare is a POM-V (Pet Prescription Required)